The global cardiac prosthetic devices market is expected to grow at a CAGR of 13.63% during the period 2017-2021.
The report, Global Cardiac Prosthetic Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
TravelWireNews Chatroom for Readers (join us)
One trend in the market is advances in technology. The demand of abnormal heart repayment has reiterated the advances in the interventional cardiology that include transcatheter aortic valve replacement (TAVR) and which further support the valve replacement through MI procedures over the open surgical procedures.
According to the report, one driver in the market is rising prevalence of cardiac disorders. The prevalence of cardiac disorders such as bradycardia, sick sinus syndrome, valvular diseases, atrioventricular blocks, ventricular fibrillation, cardiac arrest, and tachycardia has increased globally over the past few years. Cardiac arrest is a leading cause of death worldwide among adults aged above 40 years. Further, various cardiovascular disorders such as stroke, rhythm disorders, congenital heart disease, subclinical atherosclerosis, and peripheral arterial disease are other major clinical complications increasing the need for cardiac prosthetic devices. The market is also witnessing higher sales of cardiac prosthetic devices.
Further, the report states that one challenge in the market is complications associated with implantation of cardiac prosthetic devices. Although, replacement of damaged heart valve or implantation of pacemakers are considered to be prominent ways for treating a damaged heart valve or controlling abnormal heart rhythms; however, heart valve implantation is directly associated with various complications which either way restrain the market growth of cardiac prosthetic devices. The rate of acute complications with pacemaker insertion arise within a day and is higher as compared to incidence of late complications of permanent pacemaker. The complications associated with transcatheter aortic valve implantation, while treating the patient living with aortic stenosis.
- Boston Scientific
- Edward Lifesciences
- St. Jude Medical
Other prominent vendors
- Lepu medical technology
- Merit Medical
- On-X Life Technologies
- Transcatheter Technologies
Key Topics Covered:
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Research Methodology
Part 04: Introduction
Part 05: Market Landscape
Part 06: Market Sizing
Part 07: Market Segmentation By Product
Part 08: Customer Landscape
Part 09: Market Segmentation By End-User
Part 10: Regional Landscape
Part 11: Decision Framework
Part 12: Drivers And Challenges
Part 13: Market Trends
Part 14: Vendor Landscape
Part 15: Vendor Analysis
For more information about this report visit https://www.researchandmarkets.com/research/232382/global_cardiac
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets